Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis

Published:2016-11-08 Issue:11 Volume:11 Page:e0165948
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lian Xin-yue,Zhang Zhi-hui,Deng Zhao-qun,He Pin-fang,Yao Dong-ming,Xu Zi-jun,Wen Xiang-mei,Yang Lei,Lin Jiang,Qian Jun

Funder

National Natural Science Foundation of China

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. Myelodysplastic syndromes-coping with ineffective hematopoiesis;M Cazzola;N Engl J Med,2005

2. Myelodysplastic syndromes;WK Hofmann;Hematol J,2004

3. Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS);L Malcovati;Haematologica,2011

4. Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System;H Kantarjian;Cancer,2008

5. Revised International Prognostic Scoring System for myelodysplastic syndromes;PL Greenberg;Blood,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved Side Effect Profile of Alternate-Day Dosing of Lenalidomide;Cureus;2024-03-01

2. Thrombosis in Myeloid Malignancies: From CHIP to AML;Cardiovascular & Hematological Disorders-Drug Targets;2024-03

3. Impact of Lenalidomide Treatment on Overall Survival in Patients With Lower-Risk, Transfusion-Dependent Myelodysplastic Syndromes;Clinical Lymphoma Myeloma and Leukemia;2022-09

4. Novel Molecular Mechanism of Lenalidomide in Myeloid Malignancies Independent of Deletion of Chromosome 5q;Cancers;2021-10-11

5. Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy;Signal Transduction and Targeted Therapy;2021-08-30